Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conditioning regimens with HSCT in systemic sclerosis (ASSIST-IIb)
NCT01445821Phase 3Terminated
- Sponsor
- Northwestern University
- Start
- Sep 2011
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of fludarabine in systemic sclerosis (SSc), sponsored by Northwestern University. Started Sep 2011; status: terminated.
02
Drugs
fludarabine
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT01445821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445821.